Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2025-12-24 @ 11:51 PM
NCT ID: NCT00534651
Eligibility Criteria: Inclusion Criteria: * Age: 30 - 80 years * History of coronary artery disease (documented by coronary angiogram, nuclear imaging, positive stress test) * Stable cardiovascular medication for at least 1 month * Written obtained informed consent Exclusion Criteria:- myocardial infarction, unstable angina, stroke within 3 months prior to study entry * coronary intervention/revascularisation procedure within 3 months prior to study entry * Left ventricular ejection fraction \<50% * Other analgesics (Platelet inhibition therapy with Aspirin 100mg/d will be continued) * Long acting nitrates * Smoking * Chronic heart failure (\> NYHA II) * Ventricular tachyarrhythmias * Renal failure (serum creatinine \>200umol) * Liver disease (ALT or AST \>100 IU), especially acute hepatitis * Hyperbilirubinemia * Alcohol abuse * Oral Anticoagulation * Concomitant therapy with Phenobarbital, Phenytoin, Carbamazepin, Isonicotinic Acid, Chloramphenicol Chlorzoxazone, Zidovudine, Salicylamide * Insulin-dependent diabetes mellitus * Drug abuse * Anemia (Hb\<10 g/dl) * Known allergies on Paracetamol * Pregnancy * Malignancy (unless healed or remission \> 5 years) * Symptomatic hypotension, hypertension \>160/100 mmHg * Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn) * Participation in another study within the last month
Healthy Volunteers: False
Sex: ALL
Minimum Age: 30 Years
Maximum Age: 80 Years
Study: NCT00534651
Study Brief:
Protocol Section: NCT00534651